A. Borgya

1.1k total citations
6 papers, 895 citations indexed

About

A. Borgya is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, A. Borgya has authored 6 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in A. Borgya's work include Glycosylation and Glycoproteins Research (2 papers), Proteoglycans and glycosaminoglycans research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). A. Borgya is often cited by papers focused on Glycosylation and Glycoproteins Research (2 papers), Proteoglycans and glycosaminoglycans research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). A. Borgya collaborates with scholars based in Germany, United Kingdom and Sweden. A. Borgya's co-authors include Andrew Remppis, Klaus Hallermayer, Hugo A. Katus, Thomas Scheffold, Jörg Zehelein, W. Gerhardt, Christoph Ebert, Margit Müller-Bardorff, E.M. Huber and Wolfgang Rollinger and has published in prestigious journals such as Clinical Chemistry, Gene and Scandinavian Journal of Clinical and Laboratory Investigation.

In The Last Decade

A. Borgya

6 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Borgya Germany	6	656	271	163	138	60	6	895
Jörg Zehelein Germany	12	870 1.3×	252 0.9×	195 1.2×	267 1.9×	69 1.1×	21	1.0k
Donald G. Weilbaecher United States	16	639 1.0×	247 0.9×	290 1.8×	144 1.0×	82 1.4×	24	1.1k
Shinichi Nunoda Japan	14	475 0.7×	73 0.3×	413 2.5×	169 1.2×	65 1.1×	50	883
R Erny France	11	265 0.4×	129 0.5×	260 1.6×	127 0.9×	67 1.1×	32	756
Yoshiki Matoba Japan	13	770 1.2×	163 0.6×	203 1.2×	303 2.2×	129 2.1×	28	1.1k
Estelle Gandjbakhch France	21	1.5k 2.4×	70 0.3×	187 1.1×	384 2.8×	72 1.2×	101	1.8k
Robert S. Poston United States	13	173 0.3×	70 0.3×	375 2.3×	151 1.1×	49 0.8×	22	742
Gerald H. Hankes United States	12	499 0.8×	90 0.3×	135 0.8×	165 1.2×	29 0.5×	28	762
Linley E. Watson United States	13	272 0.4×	135 0.5×	202 1.2×	120 0.9×	81 1.4×	26	588
K Yoshida Japan	15	618 0.9×	242 0.9×	337 2.1×	69 0.5×	199 3.3×	29	961

Countries citing papers authored by A. Borgya

Since Specialization

Citations

This map shows the geographic impact of A. Borgya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Borgya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Borgya more than expected).

Fields of papers citing papers by A. Borgya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Borgya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Borgya. The network helps show where A. Borgya may publish in the future.

Co-authorship network of co-authors of A. Borgya

This figure shows the co-authorship network connecting the top 25 collaborators of A. Borgya. A scholar is included among the top collaborators of A. Borgya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Borgya. A. Borgya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Karl, J. Philip, et al.. (1999). Development of a novel, N-Terminal-proBNP (NT-proBNP) assay with a low detection limit. Scandinavian Journal of Clinical and Laboratory Investigation. 59(sup230). 177–181. 152 indexed citations

2.

Müller-Bardorff, Margit, Klaus Hallermayer, Christoph Ebert, et al.. (1997). Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clinical Chemistry. 43(3). 458–466. 261 indexed citations

3.

Woodman, A, Makoto Sugiyama, Kazuhiro Yoshida, et al.. (1996). Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms.. PubMed. 149(5). 1519–30. 78 indexed citations

4.

Borgya, A., et al.. (1995). Isolation and characterisation of antibodies which specifically recognise the peptide encoded by exon 7 (v2) of the human CD44 gene. Molecular Pathology. 48(5). M241–M250. 11 indexed citations

5.

Katus, Hugo A., et al.. (1992). Development and In Vitro Characterization of a New Immunoassay of Cardiac Troponin T. Clinical Chemistry. 38(3). 386–393. 361 indexed citations

6.

Weidle, Ulrich H., A. Borgya, Ralf Mattes, Helmut Lenz, & Peter Buckel. (1987). Reconstitution of functionally active antibody directed against creatine kinase from separately expressed heavy and light chains in non-lymphoid cells. Gene. 51(1). 21–29. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact